Most hospitalized patients with significant tricuspid regurgitation have advanced disease preventing transcatheter tricuspid valve intervention.

Allison O Dumitriu CarcoanaChristopher B ScomaSebastian N MaletzJose A MalavetDaniela R CrousillatFadi A Matar

Published in: Cardiovascular revascularization medicine : including molecular interventions (2024)

Only 10.0 % of patients presenting to a tertiary care center with significant TR would be candidates for TTVI when these technologies are approved in the United States. Earlier identification and treatment of TR could increase the number of patients who may benefit from interventions including TTVI.

Keyphrases

aortic valve
aortic stenosis
ejection fraction
mitral valve
tertiary care
transcatheter aortic valve replacement
end stage renal disease
randomized controlled trial
newly diagnosed
prognostic factors
peritoneal dialysis
physical activity
heart failure
case report